title: Memory of conditioned taste aversion is erased by inhibition of PI3K in the insular cortex.
abstract: The conditioned taste aversion (CTA) paradigm, in which association between a novel taste and visceral malaise is formed, gives a unique experimental setting to examine the mechanisms underlying memory acquisition and extinction processes. AKT is a main kinase of the phosphoinositide 3-kinase cascade (PI3K) and has been implicated in long-term memory. We have recently reported that blockade of PI3K in the basolateral amygdala (BLA) before retrieval of fear memory was associated with long-term reduction in fear responses, suggesting a possible role of PI3K inhibition in fear erasure. In this study, we aimed to elucidate whether PI3K has a similar role in the insular cortex (IC), which has a crucial role in CTA acquisition, consolidation, maintenance, and extinction. To that end, we (1) monitored AKT phosphorylation in the IC following CTA acquisition and extinction and (2) inhibited PI3K by local microinjection of the PI3K inhibitor LY294002 at different stages of CTA acquisition and extinction. Our results show that while AKT phosphorylation is increased following CTA learning, it is decreased following CTA extinction. Inhibition of AKT phosphorylation in the IC before or after the first CTA retrieval test resulted in reduction in the aversion index. This reduction in aversion is due to the erasure of the original CTA trace memory, as re-application of the unconditioned stimulus (lithium chloride) did not induce the recovery of aversion in LY294002-treated animals. Our present data add new evidence to suggest that PI3K is engaged in consolidation of aversive memories, as its inhibition is associated with erasure of CTA memory.
authors: Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
authors: Ilana
authors: I
authors: Slouzkey
authors: Kobi
authors: K
authors: Rosenblum
authors: Mouna
authors: M
authors: Maroun
mesh_terms: D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects / Q000502:physiology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D002867:Chromones / Q000008:administration & dosage / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005108:Extinction, Psychological / Q000502:physiology; D008297:Male; D008568:Memory / Q000187:drug effects / Q000502:physiology*; D008845:Microinjections; D009025:Morpholines / Q000008:administration & dosage / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D000081082:Phosphoinositide-3 Kinase Inhibitors; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D051381:Rats
chemical_list: D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D051057:Proto-Oncogene Proteins c-akt; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
references: Science. 2011 Mar 4;331(6021):1207-10
references: 21385716
references: J Exp Psychol Anim Behav Process. 1994 Jan;20(1):51-65
references: 8308493
references: Psychol Bull. 1993 Jul;114(1):80-99
references: 8346330
references: Behav Neurosci. 2002 Dec;116(6):1070-4
references: 12492305
references: Neuron. 2002 Nov 14;36(4):567-84
references: 12441048
references: Learn Mem. 2006 Jul-Aug;13(4):451-7
references: 16882861
references: Trends Neurosci. 2005 Jan;28(1):51-6
references: 15626497
references: Nat Rev Neurosci. 2000 Dec;1(3):214-6
references: 11257911
references: PLoS One. 2012;7(5):e35853
references: 22586453
references: Trends Neurosci. 2003 Feb;26(2):65-72
references: 12536129
references: Neurobiol Learn Mem. 2012 Jan;97(1):132-9
references: 22085719
references: J Neurosci. 2009 Jan 14;29(2):402-13
references: 19144840
references: Nat Neurosci. 2005 Jul;8(7):925-31
references: 15937483
references: Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1157-61
references: 7862652
references: J Neurosci. 1998 Dec 1;18(23):10037-44
references: 9822758
references: Brain Res. 1998 Jul 13;799(1):84-90
references: 9666086
references: Learn Mem. 2000 Mar-Apr;7(2):73-84
references: 10753974
references: J Biol Chem. 1994 Feb 18;269(7):5241-8
references: 8106507
references: Brain Res. 2007 May 7;1148:177-82
references: 17382303
references: J Neurosci. 2004 May 19;24(20):4787-95
references: 15152039
references: Science. 2003 Aug 22;301(5636):1102-4
references: 12934010
references: Learn Mem. 2003 Jan-Feb;10(1):16-25
references: 12551960
references: Neuropsychopharmacology. 2008 Jan;33(1):56-72
references: 17882236
references: Behav Neurosci. 1990 Dec;104(6):948-54
references: 2178348
references: J Neurosci. 2000 Aug 15;20(16):6225-31
references: 10934272
references: J Neurosci. 2003 Mar 1;23(5):1574-9
references: 12629159
references: Science. 1967 Jan 13;155(3759):219-20
references: 6015531
references: J Cogn Neurosci. 1989 Summer;1(3):238-43
references: 23968507
references: Eur J Neurosci. 2007 Nov;26(9):2627-32
references: 17970726
references: Neuron. 2006 May 4;50(3):479-89
references: 16675401
references: J Neurosci. 2003 May 1;23(9):3679-88
references: 12736339
references: Behav Pharmacol. 2001 Dec;12(8):629-34
references: 11856900
references: Learn Mem. 2006 May-Jun;13(3):254-8
references: 16741279
references: Science. 1955 Jul 22;122(3160):157-8
references: 14396377
references: Neuron. 2002 Oct 24;36(3):521-5
references: 12408853
references: Neuroreport. 1997 Apr 14;8(6):1363-7
references: 9172136
references: J Neurosci. 2000 Sep 15;20(18):7017-23
references: 10995847
references: Nature. 2000 Aug 17;406(6797):722-6
references: 10963596
references: Eur J Neurosci. 2003 Apr;17(7):1527-30
references: 12713656
references: Eur J Neurosci. 2006 Jun;23(12):3375-84
references: 16820027
references: Learn Mem. 2009 Oct 27;16(11):682-6
references: 19861403
references: Science. 2001 Mar 23;291(5512):2417-9
references: 11264539
references: Learn Mem. 2004 May-Jun;11(3):312-7
references: 15169861
references: Int J Neuropsychopharmacol. 2013 May;16(4):825-33
references: 22704253
references: Biochem Soc Trans. 2012 Feb;40(1):139-46
references: 22260680
references: Ann N Y Acad Sci. 2003 Apr;985:125-34
references: 12724154
references: Learn Mem. 2009 Jan 29;16(2):122-8
references: 19181618
references: Behav Neural Biol. 1993 Jan;59(1):49-56
references: 8442732
references: Cell. 1989 Oct 20;59(2):235-8
references: 2553265
references: Neuropharmacology. 2000 Feb 14;39(4):643-51
references: 10728885
references: Learn Mem. 2011 Jul 22;18(8):529-33
references: 21784922
references: Endocr Rev. 2005 Dec;26(7):916-43
references: 16131630
references: Annu Rev Psychol. 2004;55:51-86
references: 14744210
references: Learn Mem. 1999 Jan-Feb;6(1):37-46
references: 10355522
references: Ann Neurosci. 2010 Jul;17(3):136-41
references: 25205891
references: Trends Neurosci. 1988 Mar;11(3):107-11
references: 2465607
references: Front Mol Neurosci. 2011 Dec 26;4:57
references: 22207836
references: Science. 2007 Aug 17;317(5840):951-3
references: 17702943
references: Neuroreport. 2000 Jun 5;11(8):1625-30
references: 10852213
references: Behav Neurosci. 2006 Dec;120(6):1257-67
references: 17201470
references: J Comp Physiol Psychol. 1963 Apr;56:343-9
references: 13937024
references: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14599-604
references: 19706547
references: Curr Opin Neurobiol. 2006 Apr;16(2):174-8
references: 16563730
references: Nat Neurosci. 2001 Aug;4(8):813-8
references: 11477427
references: Eur J Neurosci. 2006 Sep;24(5):1434-42
references: 16965548
references: Nat Neurosci. 2008 May;11(5):572-8
references: 18425121
references: Biol Psychiatry. 2002 Nov 15;52(10):998-1007
references: 12437940
references: Neuroreport. 1995 Dec 29;7(1):289-93
references: 8742472
references: Neuron. 2001 Sep 13;31(5):841-51
references: 11567621